ChristianaCare gene-editing spinout CorriXR names new CEO


The company was launched last year with $5 million in seed financing from ChristianaCare Ventures and Brookhaven Bio.

Previous Chase's Mass. deposits skyrocket, cracking top 10 list
Next Local architecture firm to compete for up to $245M in U.S. Army Corps of Engineers contracts